Literature DB >> 1587185

Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 expression in inflammatory bowel disease.

C Stevens1, G Walz, C Singaram, M L Lipman, B Zanker, A Muggia, D Antonioli, M A Peppercorn, T B Strom.   

Abstract

The etiology of ulcerative colitis (UC) and Crohn's disease (CD) remains enigmatic. Infiltrating intestinal macrophages are capable of producing the proinflammatory cytokines tumor necrosis factor-alpha (TNF-alpha), interleukin-1 beta (IL-1 beta), and interleukin-6 (IL-6). We investigated the presence of IL-6, TNF-alpha and IL-1 beta mRNA transcripts in inflammatory bowel disease (IBD), normal, and other inflammatory intestinal specimens utilizing the polymerase chain reaction (PCR). TNF-alpha mRNA levels did not very between inflammatory bowel disease and control specimens. IL-1 beta mRNA levels were highest in active UC and noninflammatory bowel disease inflammatory specimens while IL-6 mRNA levels were highest in active IBD specimens. Infiltrating T cells, macrophages, and B cells were identified as sources of IL-6 protein in inflammatory bowel disease specimens by immunofluorescent staining. IL-6 transcripts were elevated only in active inflammatory bowel disease specimens, suggesting that IL-6-mediated immune processes are ongoing in the inflammatory mucosal environment of CD and UC.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1587185     DOI: 10.1007/bf01300378

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  37 in total

1.  Glucocorticoids inhibit transcriptional and post-transcriptional expression of interleukin 1 in U937 cells.

Authors:  P J Knudsen; C A Dinarello; T B Strom
Journal:  J Immunol       Date:  1987-12-15       Impact factor: 5.422

2.  Interleukin 6 induces secretion of IgG1 by coordinated transcriptional activation and differential mRNA accumulation.

Authors:  M C Raynal; Z Y Liu; T Hirano; L Mayer; T Kishimoto; S Chen-Kiang
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

3.  Transcriptional modulation of human IL-6 gene expression by verapamil.

Authors:  G Walz; B Zanker; C Barth; K J Wieder; S C Clark; T B Strom
Journal:  J Immunol       Date:  1990-06-01       Impact factor: 5.422

4.  IL-6/IFN-beta 2 in synovial effusions of patients with rheumatoid arthritis and other arthritides. Identification of several isoforms and studies of cellular sources.

Authors:  N Bhardwaj; U Santhanam; L L Lau; S B Tatter; J Ghrayeb; M Rivelis; R M Steinman; P B Sehgal; L T May
Journal:  J Immunol       Date:  1989-10-01       Impact factor: 5.422

5.  Arachidonic acid metabolites and their role in inflammatory bowel disease. An update requiring addition of a pathway.

Authors:  M Donowitz
Journal:  Gastroenterology       Date:  1985-02       Impact factor: 22.682

6.  Constitutive production of interleukin-6 and immunologic features in cardiac myxomas.

Authors:  M Jourdan; R Bataille; J Seguin; X G Zhang; P A Chaptal; B Klein
Journal:  Arthritis Rheum       Date:  1990-03

7.  Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin.

Authors:  B Beutler; I W Milsark; A C Cerami
Journal:  Science       Date:  1985-08-30       Impact factor: 47.728

8.  Evidence that glucocorticosteroids block expression of the human interleukin-6 gene by accessory cells.

Authors:  B Zanker; G Walz; K J Wieder; T B Strom
Journal:  Transplantation       Date:  1990-01       Impact factor: 4.939

9.  Glucocorticoids selectively inhibit the transcription of the interleukin 1 beta gene and decrease the stability of interleukin 1 beta mRNA.

Authors:  S W Lee; A P Tsou; H Chan; J Thomas; K Petrie; E M Eugui; A C Allison
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

10.  Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance.

Authors:  B Beutler; N Krochin; I W Milsark; C Luedke; A Cerami
Journal:  Science       Date:  1986-05-23       Impact factor: 47.728

View more
  90 in total

1.  Increased production of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 by inflamed mucosa in inflammatory bowel disease.

Authors:  E Louis; C Ribbens; A Godon; D Franchimont; D De Groote; N Hardy; J Boniver; J Belaiche; M Malaise
Journal:  Clin Exp Immunol       Date:  2000-05       Impact factor: 4.330

2.  IL-1beta and IL-6 excite neurons and suppress nicotinic and noradrenergic neurotransmission in guinea pig enteric nervous system.

Authors:  Y Xia; H Z Hu; S Liu; J Ren; D H Zafirov; J D Wood
Journal:  J Clin Invest       Date:  1999-05       Impact factor: 14.808

3.  Temporal genomewide expression profiling of DSS colitis reveals novel inflammatory and angiogenesis genes similar to ulcerative colitis.

Authors:  Kai Fang; Megan Bruce; Christopher B Pattillo; Songlin Zhang; Randolph Stone; John Clifford; Christopher G Kevil
Journal:  Physiol Genomics       Date:  2010-10-05       Impact factor: 3.107

Review 4.  Deciphering the role of Th17 cells in human disease.

Authors:  Cailin Moira Wilke; Keith Bishop; David Fox; Weiping Zou
Journal:  Trends Immunol       Date:  2011-09-28       Impact factor: 16.687

5.  Current directions of biologic therapies in inflammatory bowel disease.

Authors:  Catherine Reenaers; Edouard Louis; Jacques Belaiche
Journal:  Therap Adv Gastroenterol       Date:  2010-03       Impact factor: 4.409

6.  Rectal nitric oxide as biomarker in the treatment of inflammatory bowel disease: responders versus nonresponders.

Authors:  Tryggve Ljung; Sofie Lundberg; Mark Varsanyi; Catharina Johansson; Peter T Schmidt; Max Herulf; Jon O Lundberg; Per M Hellstrom
Journal:  World J Gastroenterol       Date:  2006-06-07       Impact factor: 5.742

7.  Adequacy of mucosal biopsies for evaluation of intestinal cytokine-specific mRNA. Comparative study of RT-PCR in biopsies and isolated cells from normal and inflamed intestine.

Authors:  K Fukushima; G West; C Fiocchi
Journal:  Dig Dis Sci       Date:  1995-07       Impact factor: 3.199

8.  Persistence of local cytokine production in shigellosis in acute and convalescent stages.

Authors:  R Raqib; A A Lindberg; B Wretlind; P K Bardhan; U Andersson; J Andersson
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

9.  Molecular evidence for two forms of Crohn disease.

Authors:  E C Gilberts; A J Greenstein; P Katsel; N Harpaz; R J Greenstein
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

10.  A synergistic relationship between TNF-alpha, IL-1 beta, and TGF-beta 1 on IL-6 secretion by the IEC-6 intestinal epithelial cell line.

Authors:  D W McGee; T Bamberg; S J Vitkus; J R McGhee
Journal:  Immunology       Date:  1995-09       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.